QUICK READ: Major brands are often wary of conflict, especially in a polarized time. But some are now taking a stand on racial injustice and police violence. As more CPG post their support in Black Lives Matter and the peaceful protestors big pharma is nowhere to be found. Why? Simple…they want to protect their profits and don’t want to temp Republicans from turning on them.


  • AbbVie, Humira’s manufacturer, kicked off 2020 with a price increase in excess of 7 percent on its mega-blockbuster brand-name treatment.
  • The increase followed total Humira price hikes of 19 percent during 2017 and 2018.
  • The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023.
  • AbbVie won dozens of additional patents — what critics call a “patent thicket” — that extended the exclusive market for the drug.
  • The top six executives at AbbViw make over $56.6 million.